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Abstract
Background: A low-carbohydrate diet (LCD) achieves good glycemic control in type 2 diabetes (T2DM) compared with
a high-carbohydrate diet. With respect to energy metabolism, acute metabolic responses to high-carbohydrate meals
(HCMs) have not been determined in LCD patients with T2DM.
Subjects and methods: We enrolled 31 subjects with T2DM (mean age: 62 yrs, mean hemoglobin A1c level: 6.9%), of
whom 13 were on a strict LCD (26% carbohydrate diet), and 18 a moderate one (44% carbohydrate diet). Two isocaloric
meals were administered to all subjects in a randomized crossover design. The carbohydrate:protein:fat ratios of HCMs
and low-carbohydrate meals (LCMs) were 59:20:21 and 7:20:73, respectively. Serum β-hydroxybutyrate, acetoacetate,
free fatty acids (FFAs), triglyceride and insulin, and plasma glucose concentrations were measured for 120 minutes after
the intake of each meal.
Results: HCMs rapidly decreased postprandial β-hydroxybutyrate, acetoacetate and FFA concentrations within 2 hours
in all patients in combination with rapid increases in serum insulin and plasma glucose, while LCMs increased or did not
change β-hydroxybutyrate, acetoacetate and FFAs (P < 0.001 for all). HCMs did not change postprandial triglyceride
concentrations over 2 hours, while LCMs gradually increased them (P < 0.001).
HCMs sharply and rapidly decreased postprandial β-hydroxybutyrate and acetoacetate concentrations in strict LCD
subjects over 2 hours, but only slightly decreased them in moderate LCD subjects (P < 0.001, difference between strict
and moderate LCD subjects). The parameter Δketone bodies (level at 120 minutes - level at baseline) was significantly
correlated with the insulinogenic index (Spearman's r = 0.503 for β-hydroxybutyrate and 0.509 for acetoacetate), but
not with total insulin secretory capacity. Moreover, HCMs slightly decreased postprandial triglyceride levels in strict LCD
subjects but somewhat increased them in the moderate LCD subjects (P = 0.002). The parameter Δtriglyceride was
significantly correlated with background dietary %carbohydrate (Spearman's r = 0.484).
Conclusion: HCMs rapidly decreased postprandial ketone body concentrations in T2DM patients treated with a LCD.
The decreases were more remarkable in strict than in moderate LCD subjects. HCMs slightly decreased postprandial
triglyceride levels in strict LCD subjects. The parameter Δketone bodies was significantly correlated with the
insulinogenic index, as was Δtriglyceride with background dietary %carbohydrate.
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Introduction
Low-carbohydrate diets (LCDs) are known to be more
effective than high-carbohydrate diets (HCDs) in improv-
ing glycemic control in type 2 diabetes mellitus (T2DM)
[1,2]. Our carbohydrate-reduced diet (CARD) also
showed efficacy and safety over 2 years in mild T2DM [3],
with an efficacy comparable to that provided by insulin
therapy in severe T2DM [4]. An important problem with
LCDs, however, is the high attrition rate [2,3,5]. Even
patients who strictly conform to LCDs sometimes crave a
high-carbohydrate meal (HCM), which often triggers the
patients to drop out from the LCDs.
Although a key adaptation of LCDs is the production and
utilization of ketone bodies [6,7], the potential of such
bodies for uses other than as fuels remains unclear [7].
Even moderate LCDs (30-45% carbohydrate diets) are
highly effective for T2DM and dyslipidemia [2,3,8]. Thus,
patients on a less-strict LCD sometimes eat HCMs because
they are not required to strictly limit carbohydrates. Nev-
ertheless, little is known about the acute metabolic
changes resulting from the change in carbohydrate condi-
tions in such patients.
In the present study, our subjects, T2DM outpatients on
CARD, underwent crossover meal tolerance tests (HCM
vs. a low-carbohydrate meal, LCM) to compare the acute
effects of HCMs and LCMs on postprandial serum ketone
bodies, free fatty acids (FFAs) and triglycerides. We also
compared acute responses between subjects on moderate
(non-ketogenic) and strict (ketogenic) CARD. Further-
more, for HCMs, we examined the correlation of post-
prandial changes in serum ketone bodies, FFAs and
triglycerides with an increase in postprandial plasma glu-
cose, insulin secretory capacity and background dietary
%carbohydrate.
Subjects and methods
Thirty-one volunteer T2DM outpatients from the Haim-
oto Clinic participated in the study (Table 1). All patients
were Japanese. Patients with severe diabetes complica-
tions were excluded. The participants achieved relatively
good glycemic control (mean hemoglobin A1c (HbA1c)
level: 6.9 ± 0.4%) by implementing CARD for a mean
duration of 22 months. They received no insulin, sulfony-
lurea or nateglinide treatment, and their mean HbA1c
level before CARD was 8.9 ± 2.0%. Based on their initial
HbA1c levels, 18 were assigned moderate CARD and 13
strict CARD [3,4]. Nine subjects took glucose-lowering
medication (miglitol, metformin and pioglitazone).
The HCMs and LCMs were prepared at the Haimoto
Clinic by an experienced dietitian. The total energy of the
two meals was identical, while the macronutrient compo-
sition was contrastive (Table 2). The target HCM macro-
nutrient composition followed the guidelines of the Japan
Diabetes Society [9]. The background dietary intake of the
subjects was assessed using 3-day food records.
All 31 participants underwent two-meal tolerance tests at
intervals of 7-14 days. They were randomly assigned to
two groups: 15 subjects took HCMs and LCMs in the first
and second tests, respectively, while 16 subjects received
LCMs and HCMs in the first and second sessions, respec-








Male/Female 17/14 9/9 8/5
Age (yrs) 62 ± 7 62 ± 6 62 ± 7 0.98
Body mass index 23.2 ± 3.4 22.9 ± 3.3 23.6 ± 3.5 0.56
Duration of diabetes (months) 89 ± 55 80 ± 40 101 ± 68 0.34
Duration of CARD (months) 22 ± 16 27 ± 16 16 ± 13 0.040
HbA1c (%) 6.9 ± 0.4 6.9 ± 0.4 6.8 ± 0.4 0.37
HbA1c before CARD (%) 8.9 ± 2.0 8.3 ± 1.4 9.6 ± 2.4 0.099
Serum LDL cholesterol (mg/dl) 117 ± 21 110 ± 17 126 ± 22 0.040
Serum HDL cholesterol (mg/dl) 62 ± 12 61 ± 13 64 ± 10 0.57
Serum triglyceride (mg/dl) 94 ± 42 98 ± 37 111 ± 58 0.47
Dietary intake
Total energy (kcal/day) 1808 ± 495 1713 ± 423 1990 ± 571 0.15
Carbohydrate (g/day) 158 ± 48 179 ± 35 127 ± 46 0.002
Carbohydrate (% energy) 36 ± 10 42 ± 4 26 ± 7 < 0.001
Fat (g/day) 75 ± 21 67 ± 17 92 ± 26 0.006
Fat (% energy) 38 ± 9 35 ± 5 44 ± 12 0.033
Protein (g/day) 81 ± 21 78 ± 22 90 ± 21 0.13
Protein (% energy) 18 ± 3 18 ± 3 19 ± 4 0.71
Plus-minus values are means ± SD. CARD: Carbohydrate-reduced diet, HbA1c: Hemoglobin A1c.
*: P for the difference between the moderate and strict CARD subjects.Nutrition & Metabolism 2009, 6:52 http://www.nutritionandmetabolism.com/content/6/1/52
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tively. Each meal test was conducted after a 12-hour over-
night fast. The subjects were asked to continue their CARD
and physical activity during the study period. After blood
sampling at baseline (0 minutes), the subjects were asked
to consume the test meal in 10 minutes, and blood was
collected after 30, 60 and 120 minutes. All antidiabetic
and lipid-lowering drugs were stopped for 24 hours
before each tolerance test.
Plasma glucose concentration was determined by enzy-
matic methods (Shino-Test Co. Kanagawa, Japan). Serum
immunoreactive insulin was measured using the standard
double antibody radioimmunoassay method (Fujirebio
Inc. Tokyo, Japan). Enzymatic methods were used to
measure serum total cholesterol (Sysmex Co., Hyogo,
Japan), triglycerides (Daiichi Pure Chemicals Co., Tokyo,
Japan), free fatty acids (Eiken Chemicals Co., Tokyo,
Japan), β-hydroxybutyrate and acetoacetate (Kainos Labo-
ratories Inc., Tokyo, Japan). Direct methods were used to
assay serum LDL-cholesterol and HDL-cholesterol (Dai-
ichi Pure Chemicals Co., Tokyo, Japan). HbA1c level was
measured by high-performance liquid chromatography
(Arkley Co., Kyoto, Japan).
The study protocol was approved by the Ethical Commit-
tee of the Nagoya Tokusyukai General Hospital, and all
participants provided written informed consent.
Statistical analysis
Repeated-measures analysis of variance (ANOVA) was
used to examine differences in the time course of each
substance. The baseline levels of each biomarker were
compared between the two meals by paired t-test, and
those between the moderate and strict CARD groups were
compared by unpaired t-test.
With respect to the responses to HCMs, we computed
Spearman's correlation coefficients to examine the corre-
lation of the changes in serum postprandial ketone body
(Δβ-hydroxybutyrate and Δacetoacetate), FFA (ΔFFAs)
and triglyceride (Δtriglyceride) levels with an increase in
plasma glucose levels, insulin secretory capacity and back-
ground dietary %carbohydrate as assessed by 3-day food
records. The parameters Δketone bodies, ΔFFAs and Δtrig-
lyceride were defined as the level at 120 minutes minus
the level at baseline. The incremental plasma glucose
(Δglucose) and serum insulin (Δinsulin) were calculated
as the difference between the baseline and the peak. The
trapezoidal rule was used to calculate the incremental area
under the curve for glucose (AUC-glucose) and insulin
(AUC-insulin). The HOMA-R and insulinogenic index
were computed as follows: [fasting plasma glucose (mg/
dl)] × [fasting serum insulin (μIU/ml)]/405 and ([serum
insulin at 30 minutes] - [serum insulin at baseline])/
([plasma glucose at 30 minutes] - [plasma glucose at base-
line]), respectively (9).
All values were expressed as means ± SD. P < 0.05 was con-
sidered statistically significant.
Results
Comparison between HCM and LCM
The baseline concentrations of all substances were not sig-
nificantly different between the HCM and LCM tolerance
tests (Figures 1, 2 and 3). LCMs increased postprandial
glucose and insulin concentrations only slightly (139 ± 21
mg/dl and 6.4 ± 4.6 μIU/ml at baseline, 143 ± 23 mg/dl
and 10.3 ± 6.4 μIU/ml after 30 min, 144 ± 23 mg/dl and
11.6 ± 7.4 μIU/ml after 60 min, and 142 ± 22 mg/dl and
11.4 ± 7.4 μIU/ml after 120 min, respectively), while
HCMs caused them to increase rapidly (134 ± 20 mg/dl
Table 2: Composition of test meals
Low-carbohydrate meal High-carbohydrate meal
Total energy (kcal) 500 500
Carbohydrate (% energy) 7 59
Fat (% energy) 73 21
Protein (% energy) 20 20
Carbohydrate (g) 9 73
Fat (g) 42 12
Saturated fatty acids (g) 12 3
Monounsaturated fatty acids (g) 17 3
Polyunsaturated fatty acids (g) 9 3
Protein (g) 23 23
Menu Pork back rib char boiled (86 g),
tuna salad (59 g),
mixed beans (20 g),
lettuce (10 g), 
boiled egg (50 g),
tomato (10 g)
Rice cake (140 g),
mackerel boiled Japanese bean taste (36 g),
beans and seaweeds (33 g),
cooked egg (50 g),
lettuce (10 g),
tofu (soybean curd) soup (33 g),
tomato (10 g),
apple (20 g)Nutrition & Metabolism 2009, 6:52 http://www.nutritionandmetabolism.com/content/6/1/52
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and 6.6 ± 4.7 μIU/ml at baseline, 223 ± 33 mg/dl and 21.7
± 1.5 μIU/ml after 30 min, 245 ± 42 mg/dl and 33.6 ±
21.8 μIU/ml after 60 min, and 227 ± 49 mg/dl and 34.6 ±
24.9 μIU/ml after 120 min, respectively) (P < 0.001 for
the difference between the two meals for both glucose and
insulin; Figure 1). HCMs rapidly decreased postprandial
β-hydroxybutyrate, acetoacetate and FFA concentrations,
while LCMs increased or did not change them (P < 0.001
for the difference between the two meals for all sub-
stances; Figure 2). LCMs increased postprandial triglycer-
ide concentrations, while HCMs induced little change (P
< 0.001 for the difference between the two meals;
Figure 3).
Background characteristics of the moderate and strict 
CARD groups
Background total energy intake was not significantly dif-
ferent between the two groups (Table 1). The daily average
intakes of carbohydrates and fat, however, differed
greatly, with the strict and moderate CARD groups achiev-
ing 26% and 42% carbohydrate diets, respectively. The
baseline concentrations of serum β-hydroxybutyrate and
acetoacetate were significantly higher in the strict CARD
group before HCM and LCM (P < 0.02 for all; Table 3).
Those of other substances were not significantly different
between the two groups, with the exception that the strict
CARD group showed a higher serum FFA level before the
LCM test (P = 0.04).
Differences between the moderate and strict CARDs in 
two-meal tests
No significant differences were found in the time courses
of the postprandial glucose or insulin levels between the
Postprandial glucose and insulin concentrations under HCM  (green) and LCM (orange) in all individual subjects Figure 1
Postprandial glucose and insulin concentrations 
under HCM (green) and LCM (orange) in all individ-
ual subjects. HCMs caused postprandial glucose and insulin 
concentrations to increase rapidly, while LCMs increased 
them only slightly (P < 0.001 for the difference between the 
two meals for both glucose and insulin).
Postprandial β-hydroxybutyrate, acetoacetate and FFA concentrations under HCM and LCM in all subjects Figure 2
Postprandial  -hydroxybutyrate, acetoacetate and FFA concentrations under HCM and LCM in all subjects. 
Vertical lines show means ± SD. HCMs (black square) rapidly decreased postprandial β-hydroxybutyrate, acetoacetate and FFA 
concentrations, while LCMs (white square) increased or did not change them (P < 0.001 for the difference between the two 
meals for β-hydroxybutyrate, acetoacetate and FFAs).
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moderate and strict CARD groups after the intake of HCM
and LCM (P > 0.05 for all; Table 3).
HCMs sharply decreased the postprandial serum β-
hydroxybutyrate and acetoacetate concentrations in the
strict CARD group, and only slightly decreased them in
the moderate group (Table 3, Figures 4 and 5). The time
courses were significantly different between the two
groups (P = 0.001 for both). LCMs slightly decreased the
postprandial β-hydroxybutyrate levels in the strict CARD
group, and increased them somewhat in the moderate
group (P = 0.012 for the difference in the time course;
Table 3 and Figure 4). LCMs gradually increased the post-
prandial acetoacetate concentrations in both groups (P =
0.95 for the difference in the time course; Table 3 and Fig-
ure 5). The time course of postprandial FFA concentra-
tions was not significantly different between the two
groups for both meals.
HCMs slightly decreased postprandial triglyceride levels
in the strict CARD group over 120 minutes, and slightly
increased them in the moderate group (Table 3 and Figure
6). The time courses of the two groups were significantly
different (P = 0.014). LCMs increased the levels linearly
over 120 minutes in both groups (P = 0.89 for the differ-
ence in the time course).
Correlation of changes in postprandial serum levels of 
ketone bodies, FFAs and triglycerides with insulin secretory 
capacity, background dietary %carbohydrate and 
increases in glucose levels after intake of HCM
Both Δβ-hydroxybutyrate and Δacetoacetate were strongly
and positively correlated with the insulinogenic index
(Table 4 and Figure 7), moderately and inversely with
Δglucose and AUC-glucose and moderately and positively
with background dietary %carbohydrate (Table 4 and Fig-
ure 8), while they were not significantly correlated with
Postprandial triglyceride concentrations under HCM and  LCM in all subjects Figure 3
Postprandial triglyceride concentrations under HCM 
and LCM in all subjects. Vertical lines show means ± SD. 
LCMs (white square) increased postprandial triglyceride con-
centrations, while HCMs (black square) induced little change 
(P < 0.001 for the difference between the two meals).
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Table 3: Differences in the time course for postprandial plasma glucose and serum insulin, ketone body, FFA and triglyceride levels 
between the moderate and strict CARD subjects after intake of the two meals
High-carbohydrate meal
Moderate CARD subjects (n = 18) Strict CARD subjects (n = 13) P*
Baseline 30 min 60 min 120 min Baseline 30 min 60 min 120 min
Glucose (mg/dl) 129 ± 18 214 ± 34 229 ± 35 213 ± 39 142 ± 20 223 ± 33 245 ± 42 227 ± 48 0.13
Insulin (μIU/ml) 6.2 ± 4.6 24.2 ± 13.4 36.3 ± 26.4 37.3 ± 30.8 6.2 ± 2.2 18.2 ± 7.3 29.9 ± 13.2 30.8 ± 13.6 0.51
BHB (μmol/l) 80 ± 55 33 ± 14 25 ± 7 17 ± 4 231 ± 169 104 ± 89 53 ± 39 29 ± 14 0.001
Acetoacetate(μmol/l) 22.5 ± 13.8 13.8 ± 5.3 13.5 ± 5.6 15.4 ± 4.1 60.2 ± 40.5 32.9 ± 25.4 24.3 ± 14.3 21.5 ± 7.9 0.001
FFAs (mEq/l) 0.50 ± 0.15 0.35 ± 0.13 0.24 ± 0.10 0.11 ± 0.04 0.69 ± 0.29 0.44 ± 0.14 0.31 ± 0.16 0.14 ± 0.07 0.06
Triglyceride (mg/dl) 94 ± 41 101 ± 41 103 ± 40 107 ± 43 108 ± 59 109 ± 48 106 ± 47 95 ± 44 0.014
Low-carbohydrate meal
Moderate CARD subjects (n = 18) Strict CARD subjects (n = 13) P*
Baseline 30 min 60 min 120 min Baseline 30 min 60 min 120 min
Glucose (mg/dl) 135 ± 23 137 ± 25 139 ± 25 137 ± 25 144 ± 19 151 ± 16 151 ± 19 149 ± 16 0.35
Insulin (μIU/ml) 7.1 ± 5.7 10.9 ± 7.8 12.7 ± 9.3 11.7 ± 8.8 5.5 ± 2.4 9.6 ± 3.3 10.1 ± 3.1 10.9 ± 5.2 0.67
BHB (μmol/l) 56 ± 30 51 ± 19 59 ± 23 78 ± 32 232 ± 247 187 ± 195 174 ± 211 179 ± 139 0.012
Acetoacetate (μmol/l) 17.4 ± 9.1 20.6 ± 8.0 27.1 ± 11.0 42.1 ± 22.0 56.5 ± 44.6 63.9 ± 57.9 69.0 ± 67.1 84.4 ± 51.2 0.95
FFAs (mEq/l) 0.52 ± 0.21 0.46 ± 0.22 0.46 ± 0.22 0.54 ± 0.21 0.63 ± 0.32 0.50 ± 0.15 0.52 ± 0.19 0.59 ± 0.14 0.53
Triglyceride (mg/dl) 95 ± 35 103 ± 36 125 ± 44 169 ± 62 77 ± 30 83 ± 27 108 ± 42 152 ± 71 0.89
Values are means ± SD. CARD: carbohydrate-reduced diet, BHB: β-hydroxybutyrate, FFAs: free fatty acids.
*: P for the difference in the time course between the moderate and strict CARD subjects.Nutrition & Metabolism 2009, 6:52 http://www.nutritionandmetabolism.com/content/6/1/52
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fasting plasma glucose, fasting serum insulin, Δinsulin,
AUC-insulin and HOMA-R. Namely, postprandial serum
ketone body levels decreased more in subjects with lower
insulinogenic indices. The results for Δ FFAs were similar
to those for Δketone bodies, but the correlation was some-
what weaker.
Background dietary %carbohydrate was strongly and pos-
itively correlated with Δ triglyceride and was moderately
correlated with Δβ-hydroxybutyrate and Δ acetoacetate.
The parameter Δ triglyceride was not significantly corre-
lated with any variables other than background dietary
%carbohydrate (Table 4 and Figure 8). This means that
postprandial serum triglycerides decreased more in sub-
jects with lower background dietary %carbohydrate.
Excluding the two subjects with a greatest decrease of
serum triglycerides did not materially alter the association
between Δtriglyceride and dietary %carbohydrate (Spear-
man's r = 0.487 [P = 0.007]).
In terms of the baseline levels of ketone bodies, the insuli-
nogenic index was significantly and inversely correlated
with baseline β-hydroxybutyrate and acetoacetate levels
(Spearman's r = -0.523 [P = 0.003] and -0.513 [P = 0.003],
respectively), as was dietary %carbohydrate (Spearman's r
= -0.421 [P = 0.018] and -0.443 [P = 0.013], respectively).
Discussion
The limitations of the present study are its very short term
and the large SD in serum ketone body levels before the
meal tests. Large between-person variations in fasting
serum  β-hydroxybutyrate levels have been previously
reported in outpatients after long-term LCD treatment
[10,11]. Another limitation is that the use of glucose and
lipid-lowering drugs may have affected the results.
Nevertheless, the present study demonstrated that HCMs
including 59% carbohydrates rapidly decreased postpran-
dial serum ketone body and FFA concentrations within 2
hours in T2DM outpatients on CARD. The decrease can be
explained in terms of the metabolic changes of ketone
bodies and FFAs to glucose to be used as fuel [12], which
is well-known to be largely determined by insulin secre-
tion after the intake of large amounts of carbohydrates
[12,13]. However, our study clarified that the decrease in
serum ketone body levels was much more rapid than
expected from starvation conditions [12,14] and was
more remarkable in strict (ketogenic) CARD subjects than
in moderate (non-ketogenic) CARD subjects. Carbohy-
drate or glucose administration to fasting normals causes
serum ketone body levels to decrease in a few days
[12,14]. Under low-carbohydrate conditions, unlike
under starvation conditions, a sufficient intake of protein
and fat is likely to be involved in the rapid decrease of
serum ketone body levels.
The present study also demonstrated that the insulino-
genic index was strongly and positively correlated with
Δketone bodies while concomitantly showing a strong
and inverse correlation with baseline ketone body levels,
Individual changes in postprandial β-hydroxybutyrate levels in  the moderate (orange) and strict (blue) CARD subjects after  the intake of HCM and LCM Figure 4
Individual changes in postprandial  -hydroxybutyrate 
levels in the moderate (orange) and strict (blue) 
CARD subjects after the intake of HCM and LCM.
Individual changes in postprandial acetoacetate levels in the  moderate (orange) and strict (blue) CARD subjects after the  intake of HCM and LCM Figure 5
Individual changes in postprandial acetoacetate lev-
els in the moderate (orange) and strict (blue) CARD 
subjects after the intake of HCM and LCM.
Individual changes in postprandial triglyceride levels in the  moderate (orange) and strict (blue) CARD subjects after the  intake of HCM and LCM Figure 6
Individual changes in postprandial triglyceride levels 
in the moderate (orange) and strict (blue) CARD 
subjects after the intake of HCM and LCM.Nutrition & Metabolism 2009, 6:52 http://www.nutritionandmetabolism.com/content/6/1/52
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but total insulin secretory capacity (AUC-insulin) was not
significantly correlated with Δketone bodies. A possible
interpretation of these findings is that under low-carbohy-
drate conditions, a lower insulinogenic index is probably
a factor in maintaining a high level of baseline ketone
bodies independent of dietary %carbohydrate; then, the
initial secretion of only a small amount of insulin after the
intake of LCMs leads to rapid decreases of serum post-
prandial ketone body levels.
Postprandial triglyceride levels have attracted much atten-
tion as a cardiovascular risk factor [15,16], and LCDs are
well known to improve serum triglyceride profiles com-
pared to HCDs [7,13,17]. Small amounts of dietary fats
(15 g) slightly increase postprandial serum triglyceride
levels, but never decrease them in normolipidemic adults
[18]. Interestingly, the present study demonstrated that
small amounts of fat (12 g) in HCMs slightly decreased
these levels over 2 hours in the strict CARD group in con-
trast to causing a slight increase in the moderate group.
Moreover, Δtriglyceride was strongly and positively corre-
lated with background dietary %carbohydrate, but not
with an increase in postprandial plasma glucose and
serum insulin, insulinogenic index or total insulin secre-
tory capacity. Specifically, postprandial triglyceride levels
decreased more in strict CARD subjects with lower %car-
bohydrate levels, and such patients had higher baseline
ketone body levels. Given that ketone bodies provide the
Table 4: Correlation of changes in serum ketone bodies, FFAs and triglycerides with insulin response capacity, background dietary 
%carbohydrate and increases in plasma glucose after intake of the high-carbohydrate meal
-hydroxybutyrate acetoacetate FFAs triglyceride
Fasting plasma glucose -0.261 (0.156) -0.208 (0.26) -0.208 (0.26) 0.001 (0.10)
Δglucose -0.472 (0.007) -0.442 (0.012) -0.302 (0.10) -0.250 (0.18)
AUC-glucose -0.450 (0.011) -0.407 (0.023) -0.358 (0.048) -0.149 (0.42)
Fasting serum insulin 0.279 (0.13) 0.145 (0.44) -0.114 (0.54) -0.146 (0.42)
Δinsulin 0.328 (0.072) 0.268 (0.15) 0.012 (0.95) -0.097 (0.60)
AUC-insulin 0.346 (0.057) 0.265 (0.15) -0.007 (0.97) -0.165 (0.38)
Insulinogenic index 0.503 (0.004) 0.509 (0.003) 0.359 (0.047) 0.048 (0.80)
HOMA-R 0.195 (0.292) -0.129 (0.488) 0.035 (0.85) -0.238 (0.20)
%Carbohydrate 0.380 (0.035) 0.372 (0.040) 0.268 (0.145) 0.484 (0.006)
Values indicate Spearman's r with P values in parentheses. FFAs: free fatty acids, AUC: area under curve.
Δglucose and Δinsulin: level at the peak - level at baseline.
Δβ-hydroxybutyrate, Δacetoacetate, Δfree fatty acids (ΔFFAs) and Δtriglyceride: level at 120 minutes - level at baseline.
The relationship between Δketone bodies (level at 120 minutes - level at baseline) and the insulinogenic index after the intake  of HCM Figure 7
The relationship between  ketone bodies (level at 120 minutes - level at baseline) and the insulinogenic index 
after the intake of HCM. Closed and open circles indicate subjects in the strict and moderate CARD groups, respectively. 
The parameter Δketone bodies was significantly correlated with the insulinogenic index (β-hydroxybutyrate: Spearman's r = 
0.503, P = 0.004; acetoacetate: Spearman's r = 0.509, P = 0.003).
Insulinogenic index Insulinogenic indexNutrition & Metabolism 2009, 6:52 http://www.nutritionandmetabolism.com/content/6/1/52
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same metabolic effects as insulin and inhibit lipolysis
[7,19,20], serum ketone bodies may play a role in decreas-
ing postprandial triglyceride levels. In contrast, large
amounts of fat (42 g) in LCMs increased triglyceride con-
centrations in both CARD groups. These results raise the
possibility of a threshold in the dietary fat level under
which postprandial triglyceride levels are not elevated
[21].
In summary, when T2DM patients treated with CARD
ingested HCMs, rapid metabolic change was induced
within 2 hours; a rapid decrease in serum ketone bodies
and FFA levels was found in conjunction with an increase
in postprandial glucose and insulin levels. The decrease in
ketone bodies was more remarkable in strict than in mod-
erate CARD subjects. The parameter Δketone bodies was
significantly correlated with the insulinogenic index, but
not with total insulin secetory capacity. HCMs gradually
decreased postprandial triglyceride levels in strict CARD
subjects in contrast to causing a slight increase in moder-
ate CARD subjects. The parameter Δtriglyceride was signif-
icantly correlated with dietary %carbohydrate.
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